ASSESSMENT OF METABOLIC CONTROL IN TYPE-I AND TYPE-II DIABETIC-PATIENTS BY THE DETERMINATION OF GLYCATED PLASMA-PROTEIN AND GLYCATED ALBUMIN

被引：0
|
作者：
ROHAC, M
DAMJANCIC, P
RIEDLINGER, L
LAUDON, U
ENDLER, AT
GABL, F
WALDHAUSL, W
机构：
[1] VIENNA UNIV,INST KLIN CHEM,A-1090 VIENNA,AUSTRIA
[2] VIENNA UNIV,DIAGNOST LAB,A-1090 VIENNA,AUSTRIA
[3] VIENNA UNIV,MED KLIN 1,A-1090 VIENNA,AUSTRIA
来源：
JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY | 1988年 / 26卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：765 / 765
页数：1
相关论文
共 50 条
  • [1] SERUM GLYCATED LIPOPROTEINS IN TYPE-II DIABETIC-PATIENTS WITH AND WITHOUT COMPLICATIONS
    YEGIN, A
    OZBEN, T
    ANNALS OF CLINICAL BIOCHEMISTRY, 1995, 32 : 459 - 463
  • [2] SEMIAUTOMATED DETERMINATION OF GLYCATED ALBUMIN IN GLYCEMIC CONTROL OF DIABETIC-PATIENTS
    CABRE, M
    JOVEN, J
    SIMO, JM
    MATAS, C
    CAMPS, J
    CLINICAL BIOCHEMISTRY, 1994, 27 (04) : 307 - 309
  • [3] INSULIN KINETICS IN TYPE-I AND TYPE-II DIABETIC-PATIENTS
    NAVALESI, R
    BENZI, L
    PILO, A
    MARCHETTI, P
    CECCHETTI, P
    MASONI, A
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1984, 20 (6B): : 1492 - 1492
  • [4] GLYCATED PROTEINS IN ELDERLY TYPE-II DIABETIC-PATIENTS - ROLE OF AGE AND SERUM-PROTEIN CONCENTRATION
    CARROCCIO, A
    MONTALTO, G
    SORESI, M
    LUPO, R
    DIMARTINO, D
    NOTARBARTOLO, A
    AGE AND AGEING, 1991, 20 (05) : 349 - 352
  • [5] CAPTOPRIL IN THE TREATMENT OF HYPERTENSION IN TYPE-I AND TYPE-II DIABETIC-PATIENTS
    GAMBARO, G
    MORBIATO, F
    CICERELLO, E
    DELTURCO, M
    SARTORI, L
    DANGELO, A
    CREPALDI, G
    JOURNAL OF HYPERTENSION, 1985, 3 : S149 - S151
  • [6] IMPROVED PROGNOSIS OF TYPE-I AND TYPE-II DIABETIC-PATIENTS WITH NEPHROPATHY
    HASSLACHER, C
    BORGHOLTE, G
    PANRADL, U
    WAHL, P
    MEDIZINISCHE KLINIK, 1990, 85 (11) : 643 - 646
  • [7] CAPTOPRIL IN THE TREATMENT OF HYPERTENSION IN TYPE-I AND TYPE-II DIABETIC-PATIENTS
    DANGELO, A
    SARTORI, L
    GAMBARO, G
    GIANNINI, S
    MALVASI, L
    BENETOLLO, P
    LAVAGNINI, T
    CREPALDI, G
    POSTGRADUATE MEDICAL JOURNAL, 1986, 62 : 69 - 72
  • [8] NEPHROPROTECTIVE EFFECTS OF NITRENDIPINE IN HYPERTENSIVE TYPE-I AND TYPE-II DIABETIC-PATIENTS
    BRETZEL, RG
    BOLLEN, CC
    MAESER, E
    FEDERLIN, KF
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 21 (06) : 53 - 64
  • [9] INCREASED FIBRINOLYTIC POTENTIAL INDUCED BY GLICLAZIDE IN TYPE-I AND TYPE-II DIABETIC-PATIENTS
    GRAM, J
    JESPERSEN, J
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1992, 41 (05): : 25 - 29
  • [10] EFFECTS OF DIFFERENT ANTIHYPERTENSIVE AGENTS IN NORMOTENSIVE MICROALBUMINURIC TYPE-I AND TYPE-II DIABETIC-PATIENTS
    ALLEN, T
    COOPER, ME
    JERUMS, G
    DELUISE, M
    ALFORD, F
    DOYLE, AE
    HAMMOND, J
    MASHFORD, M
    MCMENAMIN, C
    RAFFAELE, J
    WESTWOOD, B
    KIDNEY INTERNATIONAL, 1994, 45 (04) : 1270 - 1271
12345